E-Book | October 14, 2020

COVID-19 Creates A Rush For Virtual Trials

Source: Clinical Leader
20_10_CL_RushForVirtualTrials_Ebook_450x300

COVID-19 has had an extreme negative impact on countries around the world. Businesses were closed, economies were damaged, employees were forced to work form home, and everyone had to get used to wearing a mask and other practices considered to be the "new normal.” One industry that was not spared the wrath of COVID-19 was clinical trials.

The effort to protect trial participants led many companies to adopt technologies they had not used in the past. One of those is virtual or decentralized trials. Decentralized trials allow patients to participate in clinical studies without having to leave their homes. These studies make use of remote monitoring, digital devices, eDiaries, home healthcare visits, and other emerging technologies.

In this collection of articles from Clinical Leader, learn how sponsor companies are adapting to the new normal in clinical trials and reducing risk while creating tomorrow’s new study paradigms.

VIEW THE E-BOOK!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: